CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Additional Paid in Capital, Common Stock
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Additional Paid in Capital, Common Stock of $1.99 billion as of 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-08-05
- 2026-06-27: Additional Paid in Capital, Common Stock $1.99B.
- 2026-03-28: Additional Paid in Capital, Common Stock $1.97B.
- 2025-12-27: Additional Paid in Capital, Common Stock $1.95B.
- 2025-09-27: Additional Paid in Capital, Common Stock $2.02B.
| Period end | Additional Paid in Capital, Common Stock |
|---|---|
| 2026-06-27 | $1.99B 10-Q · filed 2026-08-05 |
| 2026-03-28 | $1.97B 10-Q · filed 2026-05-07 |
| 2025-12-27 | $1.95B 10-Q · filed 2026-08-05 |
| 2025-09-27 | $2.02B 10-Q · filed 2025-11-05 |
| 2025-06-28 | $1.99B 10-Q · filed 2025-08-06 |
| 2025-03-29 | $1.98B 10-Q · filed 2025-05-07 |
| 2024-12-28 | $1.97B 10-K · filed 2026-02-18 |
| 2024-09-28 | $1.97B 10-Q · filed 2024-11-06 |
| 2024-06-29 | $1.96B 10-Q · filed 2024-08-07 |
| 2024-03-30 | $1.94B 10-Q · filed 2024-05-09 |
| 2023-12-30 | $1.91B 10-K · filed 2025-02-19 |
| 2023-09-30 | $1.88B 10-Q · filed 2023-11-08 |
| 2023-07-01 | $1.85B 10-Q · filed 2023-08-09 |
| 2023-04-01 | $1.83B 10-Q · filed 2023-05-11 |
| 2022-12-31 | $1.80B 10-K · filed 2024-02-14 |
| 2022-09-24 | $1.78B 10-Q · filed 2022-11-02 |
| 2022-06-25 | $1.76B 10-Q · filed 2022-08-03 |
| 2022-03-26 | $1.74B 10-Q · filed 2022-05-04 |
| 2021-12-25 | $1.72B 10-K · filed 2023-02-22 |
| 2021-09-25 | $1.72B 10-Q · filed 2021-11-03 |
| 2021-06-26 | $1.69B 10-Q · filed 2021-08-04 |
| 2021-03-27 | $1.66B 10-Q · filed 2021-05-04 |
| 2020-12-26 | $1.63B 10-K · filed 2022-02-16 |
| 2020-09-26 | $1.61B 10-Q · filed 2020-10-29 |
| 2020-06-27 | $1.59B 10-Q · filed 2020-08-05 |
| 2020-03-28 | $1.56B 10-Q · filed 2020-05-07 |
| 2019-12-28 | $1.53B 10-K · filed 2021-02-17 |
| 2019-09-28 | $1.51B 10-Q · filed 2019-11-06 |
| 2019-06-29 | $1.50B 10-Q · filed 2019-07-31 |
| 2019-03-30 | $1.48B 10-Q · filed 2019-05-07 |
| 2018-12-29 | $1.45B 10-K · filed 2020-02-11 |
| 2018-09-29 | $2.63B 10-Q · filed 2018-11-07 |
| 2018-06-30 | $2.61B 10-Q · filed 2018-08-08 |
| 2018-03-31 | $2.59B 10-Q · filed 2018-05-10 |
| 2017-12-30 | $2.56B 10-K · filed 2019-02-13 |
| 2017-09-30 | $2.55B 10-Q · filed 2017-11-09 |
| 2017-07-01 | $2.53B 10-Q · filed 2017-08-09 |
| 2017-04-01 | $2.51B 10-Q · filed 2017-05-10 |
| 2016-12-31 | $2.48B 10-K · filed 2018-02-13 |
| 2016-09-24 | $2.47B 10-Q · filed 2016-11-02 |
| 2016-06-25 | $2.45B 10-Q · filed 2016-08-03 |
| 2016-03-26 | $2.43B 10-Q · filed 2016-05-04 |
| 2015-12-26 | $2.40B 10-K · filed 2017-02-14 |
| 2015-09-26 | $2.39B 10-Q · filed 2015-11-04 |
| 2015-06-27 | $2.37B 10-Q · filed 2015-07-30 |
| 2015-03-28 | $2.36B 10-Q · filed 2015-04-30 |
| 2014-12-27 | $2.31B 10-K · filed 2016-02-12 |
| 2014-09-27 | $2.28B 10-Q · filed 2014-10-30 |
| 2014-06-28 | $2.26B 10-Q · filed 2014-08-07 |
| 2014-03-29 | $2.25B 10-Q · filed 2014-04-30 |
| 2013-12-28 | $2.21B 10-K · filed 2015-02-17 |
| 2013-09-28 | $2.17B 10-Q · filed 2013-10-30 |
| 2013-06-29 | $2.15B 10-Q · filed 2013-07-31 |
| 2013-03-30 | $2.13B 10-Q · filed 2013-05-08 |
| 2012-12-29 | $2.10B 10-K · filed 2014-02-25 |
| 2012-09-29 | $2.09B 10-Q · filed 2012-11-01 |
| 2012-06-30 | $2.07B 10-Q · filed 2012-08-07 |
| 2012-03-31 | $2.06B 10-Q · filed 2012-05-04 |
| 2011-12-31 | $2.06B 10-K · filed 2013-02-27 |
| 2011-09-24 | $2.05B 10-Q · filed 2011-11-02 |
| 2011-06-25 | $2.04B 10-Q · filed 2011-08-03 |
| 2011-03-26 | $2.03B 10-Q · filed 2011-05-04 |
| 2010-12-25 | $2.00B 10-K · filed 2012-02-27 |
| 2010-09-25 | $1.96B 10-Q · filed 2010-11-04 |
| 2010-06-26 | $2.06B 10-Q · filed 2010-08-03 |
| 2009-12-26 | $2.04B 10-K · filed 2011-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |